"Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.
作者信息
Růžička Evžen, Zárubová Kateřina, Nutt John G, Bloem Bastiaan R
出版信息
Mov Disord. 2011 Aug 1;26(9):1782-4. doi: 10.1002/mds.23667. Epub 2011 Apr 14.
Abstract
摘要
相似文献
1
"Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.帕金森病中的“滑稽步态”：多巴胺能诱导的异动症的不寻常表现。
Mov Disord. 2011 Aug 1;26(9):1782-4. doi: 10.1002/mds.23667. Epub 2011 Apr 14.
2
The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches.谷氨酸能传递在左旋多巴诱导的异动症发病机制中的作用。潜在的治疗方法。
Neurol Neurochir Pol. 2001;35 Suppl 3:65-8.
3
Lees' syndrome: a case series.
Arq Neuropsiquiatr. 2011 Oct;69(5):756-9. doi: 10.1590/s0004-282x2011000600006.
4
Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?峰值剂量运动障碍；这是晚期帕金森病中为保持活动能力所付出的可接受代价吗？
Clin Neurophysiol. 2005 Sep;116(9):1997-8. doi: 10.1016/j.clinph.2005.06.009.
5
Therapies for dopaminergic-induced dyskinesias in Parkinson disease.
Ann Neurol. 2011 Oct;70(4):667; author reply 667-8. doi: 10.1002/ana.22604.
6
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.帕金森病中左旋多巴诱发的异动症：临床特征、发病机制、预防及治疗
Postgrad Med J. 2007 Jun;83(980):384-8. doi: 10.1136/pgmj.2006.054759.
7
Rating scales for dyskinesias in Parkinson's disease.帕金森病异动症的评定量表。
Mov Disord. 1999;14 Suppl 1:48-53.
8
Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease.罗匹尼罗单药治疗可诱发帕金森病严重的可逆性运动障碍。
Mov Disord. 2013 Jul;28(8):1159-60. doi: 10.1002/mds.25318. Epub 2013 Feb 5.
9
Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.5-羟色胺能系统参与帕金森病左旋多巴诱导的运动障碍。
J Clin Neurosci. 2012 Mar;19(3):343-8. doi: 10.1016/j.jocn.2011.09.008. Epub 2012 Jan 16.
10
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.帕金森病患者左旋多巴诱发的剂峰异动症：一种临床药理学方法
Mov Disord. 1999;14 Suppl 1:19-32.
引用本文的文献
1
Unveiling the Unpredictable in Parkinson's Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life.揭示帕金森病中的不可预测因素：基于传感器的日常生活中异动症和步态冻结监测
Bioengineering (Basel). 2024 Apr 29;11(5):440. doi: 10.3390/bioengineering11050440.
2
[Additional functional symptoms in Parkinson's disease and tremor syndromes].[帕金森病和震颤综合征中的附加功能症状]
Nervenarzt. 2024 Jun;95(6):525-531. doi: 10.1007/s00115-023-01594-1. Epub 2024 Jan 5.
3
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.帕金森病左旋多巴诱导性异动症的视频图谱：术语很重要。
Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21.
4
Adapting STN-DBS Stimulation Pattern for the Treatment of "Choreo Dystonic Lower Limb Dyskinesia" in Parkinson's Disease.调整丘脑底核深部脑刺激（STN-DBS）刺激模式以治疗帕金森病中的“舞蹈样肌张力障碍性下肢运动障碍”
Mov Disord Clin Pract. 2022 Nov 11;10(2):323-325. doi: 10.1002/mdc3.13607. eCollection 2023 Feb.
5
Clinical neurophysiology of Parkinson's disease and parkinsonism.帕金森病及帕金森综合征的临床神经生理学
Clin Neurophysiol Pract. 2022 Jun 30;7:201-227. doi: 10.1016/j.cnp.2022.06.002. eCollection 2022.
6
Pearls & Oy-sters: Marionette Walk in Parkinson Disease: A Rare Dyskinetic-Dystonic Gait Pattern Complication Improved by Visual Cueing.珍珠与牡蛎：帕金森病的木偶步态：一种罕见的运动障碍-肌张力障碍步态模式并发症，通过视觉提示得到改善。
Neurology. 2022 Jul 11;99(2):77-81. doi: 10.1212/WNL.0000000000200714.
7
Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation.对《苍白球深部脑刺激成功治疗左旋多巴/卡比多巴肠凝胶相关的“双相样”异动症》评论的回复
Mov Disord Clin Pract. 2021 Apr 26;8(5):814-815. doi: 10.1002/mdc3.13221. eCollection 2021 Jul.
8
Functional Dyskinesias following Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Report of Three Cases.帕金森病丘脑底核深部脑刺激术后的功能性运动障碍：三例报告
Mov Disord Clin Pract. 2020 Dec 2;8(1):114-117. doi: 10.1002/mdc3.13111. eCollection 2021 Jan.
9
Functional gait disorders: A sign-based approach.功能性步态障碍：基于征象的方法。
Neurology. 2020 Jun 16;94(24):1093-1099. doi: 10.1212/WNL.0000000000009649. Epub 2020 Jun 1.
10
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.左旋多巴诱导的运动障碍：临床特征、发生率和危险因素。
J Neural Transm (Vienna). 2018 Aug;125(8):1109-1117. doi: 10.1007/s00702-018-1900-6. Epub 2018 Jul 3.
本文引用的文献
1
Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.心因性帕金森综合征：临床、电生理及[（123）I]-FP-CIT单光子发射计算机断层扫描检查相结合可提高诊断准确性。
Mov Disord. 2006 Mar;21(3):310-7. doi: 10.1002/mds.20720.
2
A video review of the diagnosis of psychogenic gait: appendix and commentary.精神性步态诊断的视频回顾：附录与评论
Mov Disord. 1999 Nov;14(6):914-21. doi: 10.1002/1531-8257(199911)14:6<914::aid-mds1002>3.0.co;2-b.
3
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.帕金森病中左旋多巴诱发的异动症：现象学与病理生理学
Mov Disord. 1994 Jan;9(1):2-12. doi: 10.1002/mds.870090103.
4
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?帕金森症状和左旋多巴诱发的异动症是从足部开始的吗？
Neurology. 1994 Sep;44(9):1613-6. doi: 10.1212/wnl.44.9.1613.
5
Young onset Parkinson's disease.早发型帕金森病
Mov Disord. 1987;2(2):73-91. doi: 10.1002/mds.870020201.
6
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.左旋多巴诱发异动症的起始与剂末现象。增加左旋多巴每日剂量的可能治疗方法。
Arch Neurol. 1978 May;35(5):261-3. doi: 10.1001/archneur.1978.00500290007002.
Zotero 插件